BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17468387)

  • 1. Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene.
    Kreek MJ; LaForge KS
    Mol Interv; 2007 Apr; 7(2):74-8. PubMed ID: 17468387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
    Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
    J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.
    van den Wildenberg E; Wiers RW; Dessers J; Janssen RG; Lambrichs EH; Smeets HJ; van Breukelen GJ
    Alcohol Clin Exp Res; 2007 Jan; 31(1):1-10. PubMed ID: 17207095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.
    Bart G; Kreek MJ; Ott J; LaForge KS; Proudnikov D; Pollak L; Heilig M
    Neuropsychopharmacology; 2005 Feb; 30(2):417-22. PubMed ID: 15525999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.
    Franke P; Wang T; Nöthen MM; Knapp M; Neidt H; Albrecht S; Jahnes E; Propping P; Maier W
    Am J Med Genet; 2001 Jan; 105(1):114-9. PubMed ID: 11424981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances.
    Schinka JA; Town T; Abdullah L; Crawford FC; Ordorica PI; Francis E; Hughes P; Graves AB; Mortimer JA; Mullan M
    Mol Psychiatry; 2002; 7(2):224-8. PubMed ID: 11840318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain.
    Janicki PK; Schuler G; Francis D; Bohr A; Gordin V; Jarzembowski T; Ruiz-Velasco V; Mets B
    Anesth Analg; 2006 Oct; 103(4):1011-7. PubMed ID: 17000822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the mu opioid receptor gene polymorphism A118G in patients with primary biliary cirrhosis with and without pruritus.
    Wei LX; Floreani A; Variola A; El Younis C; Bergasa NV
    Acta Derm Venereol; 2008; 88(4):323-6. PubMed ID: 18709298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis.
    Arias A; Feinn R; Kranzler HR
    Drug Alcohol Depend; 2006 Jul; 83(3):262-8. PubMed ID: 16387451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia.
    Sia AT; Lim Y; Lim EC; Goh RW; Law HY; Landau R; Teo YY; Tan EC
    Anesthesiology; 2008 Sep; 109(3):520-6. PubMed ID: 18719451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy.
    Liu YC; Wang WS
    Cancer; 2012 Mar; 118(6):1718-25. PubMed ID: 21837673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency.
    Town T; Abdullah L; Crawford F; Schinka J; Ordorica PI; Francis E; Hughes P; Duara R; Mullan M
    Am J Med Genet; 1999 Oct; 88(5):458-61. PubMed ID: 10490697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms.
    Ide S; Kobayashi H; Ujike H; Ozaki N; Sekine Y; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Iwata N; Tanaka K; Shen H; Iwahashi K; Itokawa M; Minami M; Satoh M; Ikeda K; Sora I
    Pharmacogenomics J; 2006; 6(3):179-88. PubMed ID: 16402083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers.
    Oertel BG; Schmidt R; Schneider A; Geisslinger G; Lötsch J
    Pharmacogenet Genomics; 2006 Sep; 16(9):625-36. PubMed ID: 16906017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
    Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
    J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque.
    Vallender EJ; Priddy CM; Chen GL; Miller GM
    Behav Genet; 2008 Jul; 38(4):390-5. PubMed ID: 18379868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individual differences in analgesic effects of narcotics].
    Ide S; Kasai S; Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception.
    Matsunaga M; Isowa T; Murakami H; Kasugai K; Yoneda M; Kaneko H; Ohira H
    Brain Behav Immun; 2009 Oct; 23(7):931-5. PubMed ID: 19341791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.
    Oslin DW; Berrettini WH; O'Brien CP
    Addict Biol; 2006 Sep; 11(3-4):397-403. PubMed ID: 16961767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.